Your browser doesn't support javascript.
loading
Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Weaver, Kimberly N; Zhang, Xian; Dai, Xiangfeng; Watkins, Runa; Adler, Jeremy; Dubinsky, Marla C; Kastl, Arthur; Bousvaros, Athos; Strople, Jennifer A; Cross, Raymond K; Higgins, Peter D R; Ungaro, Ryan C; Bewtra, Meenakshi; Bellaguarda, Emanuelle; Farraye, Francis A; Boccieri, Margie E; Firestine, Ann; Kappelman, Michael D; Long, Millie D.
Afiliação
  • Weaver KN; Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Zhang X; Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Dai X; Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Watkins R; Division of Pediatric Gastroenterology and Nutrition, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Adler J; Susan B. Meister Child Health Evaluation and Research Center and Division of Pediatric Gastroenterology, University of Michigan, Ann Arbor, MI, USA.
  • Dubinsky MC; Susan and Leonard Feinstein IBD Center, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Kastl A; Division of Gastroenterology, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Bousvaros A; Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
  • Strople JA; Department of Pediatrics, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
  • Cross RK; Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, MD, USA.
  • Higgins PDR; Division of Gastroenterology & Hepatology, University of Michigan, Ann Arbor, MI, USA.
  • Ungaro RC; Susan and Leonard Feinstein IBD Center, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Bewtra M; Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA, USA.
  • Bellaguarda E; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA, USA.
  • Farraye FA; Division of Gastroenterology and Hepatology, Northwestern University, Chicago, IL, USAand.
  • Boccieri ME; Division of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
  • Firestine A; Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Kappelman MD; Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Long MD; Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Inflamm Bowel Dis ; 28(10): 1497-1505, 2022 10 03.
Article em En | MEDLINE | ID: mdl-34871388
The severe acute respiratory syndrome coronavirus 2 vaccine is safe and well tolerated among individuals with inflammatory bowel disease (IBD). Severe localized and systemic vaccine-related adverse events were rare, and rates of IBD flare were low (2%) following severe acute respiratory syndrome coronavirus 2 vaccination in a cohort of 3316 participants with IBD.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article